May 2009 Issue of MMM
Somebody asked me a few days ago why I bother to tweet. "What's the point of Twitter?" he continued.
The deadline to enter the MM&M Awards is merely weeks away but rest assured that your entries will be in good hands. James Chase reveals, ...
2008 was a tough year for the industry. Big Pharma is in a temporary holding pattern as companies pursue a broader-based portfolio that includes non-traditional ...
Shire product director Mike Boken uses the example of ADHD drug Vyvanse to illustrate the potential pharmaceutical marketing advantages of using patient debit, copay and ...
Measuring online consumer healthcare conversations can help provide pharma companies with insights for message planning, competitive intelligence and new product development. Ira Haimowitz and Claudia ...
Alex Gorsky, worldwide chairman for Johnson & Johnson's surgical care group and this year's Healthcare Businesswomen's Association Honorable Mentor, says mentoring is a two-way street.
Waste not, want not. This phrase is typically credited to Ben Franklin, but its profoundness was evident throughout the PMRG meeting in Las Vegas in ...
I haven't covered prostate cancer in this space before, in part because the choices, though controversial, have been somewhat static for some time.
Several prominent universities have banned gifts from pharma companies, including everything from paid lunches to drug samples, and the trend seems likely to continue.
Physicians Interactive (PI) acquired MedManage Systems Inc., a provider of online, on-demand prescription drug sampling.
According to a new study by Manhattan Research, video detailing is now a viable option for pharma, biotech and device manufacturers.
Med Ed Report
The American Psychiatric Association will put an end to industry-sponsored continuing medical education and meals served during its annual meetings.
Iowa's state Senate passed a healthcare bill containing some of the toughest restrictions on drug company contacts with physicians yet.
A magazine focused on chronic, acute and cancer-related pain made the leap onto consumer newsstands in April, debuting at Barnes & Noble stores nationwide.
InnoVision Health Media, publisher of three complimentary and alternative medicine journals, and consumer magazine Natural Solutions, was acquired by private-equity firms: American Securities and ACI ...
The AMA is the latest association to call for an increasingly limited financial relationship with pharma. With less opportunity for sponsorships, will journal advertising and ...
The number of physicians using smartphones in 2009 surged to 64%, according to the results of a study by Manhattan Research.
A new online health community—FacetoFace Health— is pairing patients with other patients based on similar conditions and medications.
Sensei, a mobile technology developer and subsidiary of Humana, has launched an iPhone app for diabetics.
Hooray for Galderma and their new campaign for Oracea (pronounced or-A-sha) that treats rosacea (pronounced roh-ZAY-sha).
TV ads for prescription drugs loosened up a bit in 2008 and exercised greater creativity despite intense scrutiny, The Nielsen Company found in a review ...
AstraZeneca is redeploying its Artery Explorer for a second tour, using medical animation to help bring atherosclerosis to life.
Citing studies, American Medical News said simplified drug packaging might improve patients' comprehension of risks and benefits but seems to have little impact on adherence.
Marketers must appeal less to the emotions and more to ration to woo consumers amid the economic downturn, according to a DDB study.
IMS Health and SDI are seeking a Supreme Court review of a ruling that restricts the commercial use of prescriber data in the state of ...
Healthcare marketing research firm G&S Research promoted Mike Bandick to SVP. The move follows a company restructuring that put Bandick at the head of R&S ...
Database marketing agency Merkle has launched a healthcare practice, led by former GlaxoSmithKline director of integrated marketing Jeff Wiltrout.
Global PR firm Burson-Marsteller has appointed Lisa Davidson to managing director of the firm's global healthcare practice.
When it comes to the future of the FDA, sources inside the Obama administration assure me that they have no plans to bifurcate food/tobacco from ...
Drug companies that shop among competing institutional review boards, especially those that operate for profit, to get the most favorable clinical study results, and a ...
Washington Legal Foundation (WLF) said the US Supreme Court's recent 6-3 decision that federal law generally does not pre-empt state law product liability suits challenging ...
Remember what happened with websites in the 1990s? It seemed as if corporate marketing went from "Exactly how do they work?" to "Wow, we gotta ...
The need for increased health and science literacy has never been greater. It's a crucial gap that must be filled if we are to promote ...
Again and again you see the statement that information technology will not only avoid medication errors but stop (or even reverse) the upward trend of ...
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.